Geoff Martha oversaw the Covidien-Medtronic combination. Now he leads some of the giant’s more exciting businesses. Hear how he views Medtech and Medtronic’s role in changing it.
Geoff Martha was named Executive Vice President and Group President for the Restorative Therapies Group in June, 2015, and is a member of the Company’s Executive Committee.
00:28 – What groups fall under your management?
01:30 – Tell us about your agreement with Mazor.
02:45 – This is a bet on robotics today, not just the future.
04:00 – Where is the challenge greatest? In emerging or established markets?
07:40 – Who is most resistant to change? Payers? Providers? Patients?
08:15 – Will value-based health care kill innovation?
09:25 – Is the UnitedHealth-Medtronic deal the first of many arrangements?
10:12 – Payers and device companies genuinely care about our patients.
10:39 – I think people want to do what’s right for the health care system.
10:35 – The move from volume to value has left the station.
12:12 – What does play big and play small mean for Medtronic.